104 related articles for article (PubMed ID: 31004283)
1. Frailty index is associated with increased risk of elevated BNP in an elderly population: the Rugao Longevity and Ageing Study.
Wang ZD; Yao S; Shi GP; Wang Y; Shi JM; Guo JH; Zhu YS; Jiang XY; Chu XF; Wang XF
Aging Clin Exp Res; 2020 Feb; 32(2):305-311. PubMed ID: 31004283
[TBL] [Abstract][Full Text] [Related]
2. Frailty phenotype, frailty index and risk of mortality in Chinese elderly population- Rugao longevity and ageing study.
Shi GP; Ma T; Zhu YS; Wang ZD; Chu XF; Wang Y; Chen ZK; Xu WD; Wang XF; Guo JH; Jiang XY
Arch Gerontol Geriatr; 2019; 80():115-119. PubMed ID: 30448694
[TBL] [Abstract][Full Text] [Related]
3. Association of BNP with Frailty in Elderly Population: Rugao Longevity and Ageing Study.
Yao S; Guo J; Shi G; Zhu Y; Wang Y; Chu X; Jiang X; Jin L; Wang Z; Wang X
J Nutr Health Aging; 2019; 23(1):73-78. PubMed ID: 30569072
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptides for the prediction of cardiovascular events and mortality in patients living with HIV: Results from the HIV-HEART study.
Reinsch N; Streeck H; Holzendorf V; Schulze C; Neumann T; Brockmeyer NH; Kehrmann J; Schadendorf D; Esser S;
Int J Cardiol; 2019 Apr; 281():127-132. PubMed ID: 30711264
[TBL] [Abstract][Full Text] [Related]
5. Associations of TNF-α -308 G>A and TNF-β 252 A>G with Physical Function and BNP-Rugao Longevity and Ageing Study.
Yao S; Zhu YS; Shi GP; Guo JH; Wang ZD; Chu XF; Jiang XY; Jin L; Wang XF
J Nutr Health Aging; 2020; 24(3):358-363. PubMed ID: 32115620
[TBL] [Abstract][Full Text] [Related]
6. Association between a frailty index based on common laboratory tests and QTc prolongation in older adults: the Rugao Longevity and Ageing Study.
Ma T; Cai J; Zhu YS; Chu XF; Wang Y; Shi GP; Wang ZD; Yao S; Wang XF; Jiang XY
Clin Interv Aging; 2018; 13():797-804. PubMed ID: 29731619
[TBL] [Abstract][Full Text] [Related]
7. NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study.
Kara K; Lehmann N; Neumann T; Kälsch H; Möhlenkamp S; Dykun I; Broecker-Preuss M; Pundt N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
Int J Cardiol; 2015 Mar; 183():155-61. PubMed ID: 25666125
[TBL] [Abstract][Full Text] [Related]
8. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
[TBL] [Abstract][Full Text] [Related]
9. Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study.
Kara K; Mahabadi AA; Berg MH; Lehmann N; Möhlenkamp S; Kälsch H; Bauer M; Moebus S; Dragano N; Jöckel KH; Neumann T; Erbel R
Eur J Prev Cardiol; 2014 Sep; 21(9):1171-9. PubMed ID: 23674833
[TBL] [Abstract][Full Text] [Related]
10. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.
Inohara T; Kim S; Pieper K; Blanco RG; Allen LA; Fonarow GC; Gersh BJ; Ezekowitz MD; Kowey PR; Reiffel JA; Naccarelli GV; Chan PS; Mahaffey KW; Singer DE; Freeman JV; Steinberg BA; Peterson ED; Piccini JP;
Heart; 2019 Mar; 105(5):370-377. PubMed ID: 30228248
[TBL] [Abstract][Full Text] [Related]
12. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies.
Karthikeyan G; Moncur RA; Levine O; Heels-Ansdell D; Chan MT; Alonso-Coello P; Yusuf S; Sessler D; Villar JC; Berwanger O; McQueen M; Mathew A; Hill S; Gibson S; Berry C; Yeh HM; Devereaux PJ
J Am Coll Cardiol; 2009 Oct; 54(17):1599-606. PubMed ID: 19833258
[TBL] [Abstract][Full Text] [Related]
13. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
[TBL] [Abstract][Full Text] [Related]
14. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
15. Sex-specific threshold levels of plasma B-type natriuretic peptide for prediction of cardiovascular event risk in a Japanese population initially free of cardiovascular disease.
Nakamura M; Tanaka F; Takahashi T; Makita S; Ishisone T; Onodera M; Ishibashi Y; Itai K; Onoda T; Ohsawa M; Tanno K; Sakata K; Shinichi O; Ogasawara K; Ogawa A; Kuribayashi T; Okayama A
Am J Cardiol; 2011 Dec; 108(11):1564-9. PubMed ID: 21871591
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels.
Daniels LB; Clopton P; Jiang K; Greenberg B; Maisel AS
J Card Fail; 2010 Feb; 16(2):93-8. PubMed ID: 20142019
[TBL] [Abstract][Full Text] [Related]
17. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
18. Association of depressive symptoms with cardiovascular events and plasma BNP: A prospective cohort study of the elderly Chinese population.
Wang X; Shi J; Jiang X; Wang X
Arch Gerontol Geriatr; 2024 Aug; 123():105413. PubMed ID: 38555650
[TBL] [Abstract][Full Text] [Related]
19. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.
Fatemi S; Acosta S; Gottsäter A; Melander O; Engström G; Dakhel A; Zarrouk M
Biomarkers; 2019 Sep; 24(6):615-621. PubMed ID: 31215249
[No Abstract] [Full Text] [Related]
20. B-type natriuretic peptide for incident atrial fibrillation-The Heinz Nixdorf Recall Study.
Kara K; Geisel MH; Möhlenkamp S; Lehmann N; Kälsch H; Bauer M; Neumann T; Dragano N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
J Cardiol; 2015 Jun; 65(6):453-8. PubMed ID: 25241013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
